Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05352581 · ClinicalTrials.gov registry record
BD Veritor™ At-Home and BD Veritor™ Professional
A clinical trial, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 1,146
- Enrollment target
NCT05352581 is a clinical trial that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 1,146 participants.
The verdict
NCT05352581 has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 1,146 participants
- Enrollment target
Study Summary
The BD Veritor™ System is a rapid test that is testing for both COVID-19 and for Influenza This study will try to determine if the BD Veritor™ system can assist in the diagnosis of someone who has upper respiratory infection symptoms. There is both an At-Home self test and test completed by a health care professional that will be completed during this study.
Interventions
- DIAGNOSTIC_TEST BD Veritor At-Home
- DIAGNOSTIC_TEST BD Veritor Professional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,146 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2023-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05352581
The ClinicalTrials.gov registry entry for NCT05352581 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BD Veritor At-Home is the first listed.
NCT05352581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05352581 about?
NCT05352581 is a clinical study titled "BD Veritor™ At-Home and BD Veritor™ Professional". The BD Veritor™ System is a rapid test that is testing for both COVID-19 and for Influenza This study will try to determine if the BD Veritor™ system can assist in the diagnosis of someone who has upper respiratory infection symptoms. There is both an At-Home self test and test completed by a health...
What is the current status of trial NCT05352581?
This trial is currently completed. The enrollment target is 1,146 participants. The study started on 2022-07-21. Estimated completion is 2023-04-14.
What interventions are being tested in trial NCT05352581?
The interventions under investigation include: BD Veritor At-Home (DIAGNOSTIC_TEST), BD Veritor Professional (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05352581?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.